Cochrane Clinical Answers - Access Denied - How do anti-vascular endothelial growth factor (VEGF) drugs compare with conventional laser therapy for treatment of infants with retinopathy of prematurity?

Question:How do anti-vascular endothelial growth factor (VEGF) drugs compare with conventional laser therapy for treatment of infants with retinopathy of prematurity?

THIS CLINICAL ANSWER IS UPDATED

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer compares vascular endothelial growth factor (VEGF) drugs versus conventional laser therapy for treatment of people with retinopathy of prematurity.

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.